| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 9.489 | 56.998 | 103.007 | 124.149 | 115.061 | 108.557 |
| Total Income - EUR | - | - | - | - | 9.489 | 56.998 | 103.007 | 124.149 | 116.308 | 108.557 |
| Total Expenses - EUR | - | - | - | - | 1.871 | 3.313 | 2.325 | 4.190 | 23.029 | 26.652 |
| Gross Profit/Loss - EUR | - | - | - | - | 7.618 | 53.685 | 100.682 | 119.959 | 93.279 | 81.905 |
| Net Profit/Loss - EUR | - | - | - | - | 7.333 | 51.975 | 98.052 | 117.110 | 92.290 | 78.649 |
| Employees | - | - | - | - | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Semuromed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 35.490 | 26.537 | 17.593 |
| Current Assets | - | - | - | - | 7.554 | 53.949 | 115.584 | 109.693 | 99.707 | 81.581 |
| Inventories | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 2.229 | 46.838 | 8.470 | 97.651 | 18.209 | 57.495 |
| Cash | - | - | - | - | 5.325 | 7.111 | 107.114 | 12.043 | 81.497 | 24.086 |
| Shareholders Funds | - | - | - | - | 7.375 | 52.025 | 113.749 | 117.159 | 99.662 | 78.767 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 179 | 1.924 | 1.835 | 28.025 | 26.582 | 20.406 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Semuromed S.r.l.